BR0214159A - Sistema farmacêutico radiopaco de liberação prolongada - Google Patents

Sistema farmacêutico radiopaco de liberação prolongada

Info

Publication number
BR0214159A
BR0214159A BR0214159-0A BR0214159A BR0214159A BR 0214159 A BR0214159 A BR 0214159A BR 0214159 A BR0214159 A BR 0214159A BR 0214159 A BR0214159 A BR 0214159A
Authority
BR
Brazil
Prior art keywords
radiopaque
pharmaceutically active
sustained release
release pharmaceutical
prolonged release
Prior art date
Application number
BR0214159-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Malcolm Brandon
Serge R Martinod
Original Assignee
Smart Drug Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smart Drug Systems Inc filed Critical Smart Drug Systems Inc
Publication of BR0214159A publication Critical patent/BR0214159A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR0214159-0A 2001-12-14 2002-12-09 Sistema farmacêutico radiopaco de liberação prolongada BR0214159A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR9515A AUPR951501A0 (en) 2001-12-14 2001-12-14 Modified sustained release pharmaceutical system
PCT/AU2002/001661 WO2003051335A1 (en) 2001-12-14 2002-12-09 Radioopaque sustained release pharmaceutical system

Publications (1)

Publication Number Publication Date
BR0214159A true BR0214159A (pt) 2004-09-28

Family

ID=3833131

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214159-0A BR0214159A (pt) 2001-12-14 2002-12-09 Sistema farmacêutico radiopaco de liberação prolongada

Country Status (9)

Country Link
US (1) US20050063907A1 (https=)
EP (1) EP1453482A4 (https=)
JP (1) JP2005517653A (https=)
CN (1) CN1589133A (https=)
AU (1) AUPR951501A0 (https=)
BR (1) BR0214159A (https=)
CA (1) CA2468986A1 (https=)
NZ (1) NZ532378A (https=)
WO (1) WO2003051335A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
WO2004026111A2 (en) 2000-11-16 2004-04-01 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
AU2003201410B2 (en) * 2002-01-24 2008-07-03 Virbac Corporation Sustained release pharmaceutical composition
US8920826B2 (en) * 2002-07-31 2014-12-30 Boston Scientific Scimed, Inc. Medical imaging reference devices
NZ575950A (en) * 2003-11-13 2010-06-25 Psivida Inc Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin
TWI434676B (zh) 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用ｘ射線看出之藥物遞送裝置
DE102006021016A1 (de) * 2006-05-05 2007-11-15 Dürschinger, Günter Chemisch aktivierbare Kapsel für die Durchgangsprüfung und Behandlung des Darm-Trakts
US8956642B2 (en) * 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
US8940315B2 (en) * 2008-04-18 2015-01-27 Medtronic, Inc. Benzodiazepine formulation in a polyorthoester carrier
US20100203102A1 (en) * 2009-02-10 2010-08-12 Warsaw Orthopedic, Inc. Compositions and methods for treating post-operative pain using bupivacaine and an anti-onflammatory agent
BRPI1009345A2 (pt) * 2009-03-17 2016-03-08 Intervet Int Bv sistema de administracao de droga, uso de um sistema de administracao de droga, e, metodo pata tratar doencas
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法
WO2016204026A1 (ja) * 2015-06-15 2016-12-22 ｓｅｖｅｎ ｄｒｅａｍｅｒｓ ｌａｂｏｒａｔｏｒｉｅｓ株式会社 鼻腔留置デバイス
US11096781B2 (en) 2016-08-01 2021-08-24 Edwards Lifesciences Corporation Prosthetic heart valve
CN216854956U (zh) 2020-08-24 2022-07-01 爱德华兹生命科学公司 假体心脏瓣膜

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD205069A1 (de) * 1982-04-14 1983-12-21 Univ Ernst Moritz Arndt Verfahren zur herstellung eines therapeutischen mittels
US4866132A (en) * 1986-04-17 1989-09-12 The Research Foundation Of State University Of New York Novel radiopaque barium polymer complexes, compositions of matter and articles prepared therefrom
DE3775880D1 (https=) * 1986-09-18 1992-02-20 London School Of Pharmacy Innovations Ltd., London, Gb
ATE108651T1 (de) * 1988-05-20 1994-08-15 Liposome Co Inc Aktives mittel: lipid-komplex mit hohem verhältnis.
GB9204918D0 (en) * 1992-03-06 1992-04-22 Nycomed As Chemical compounds
US5674468A (en) * 1992-03-06 1997-10-07 Nycomed Imaging As Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons
LV10396B (en) * 1992-03-06 1996-02-20 Nycomed Imaging As Novel contrast agents
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
AU689622B2 (en) * 1994-08-17 1998-04-02 Boston Scientific Corporation Implant, and method and device for inserting the implant
AU716005B2 (en) * 1995-06-07 2000-02-17 Cook Medical Technologies Llc Implantable medical device
UA54505C2 (uk) * 1997-04-03 2003-03-17 Гілфорд Фармасьютікалз Інк. Полімери, що біологічно розкладаються, зшиті фосфатами, композиції, вироби і способи для їх виготовлення і використання
EP0938894A1 (en) * 1998-02-16 1999-09-01 Biomat B.V. Implantable radiopaque device and use thereof
IL133196A0 (en) * 1999-11-29 2001-03-19 Yissum Res Dev Co Gastroretentive controlled release pharmaceutical dosage forms
US6599448B1 (en) * 2000-05-10 2003-07-29 Hydromer, Inc. Radio-opaque polymeric compositions

Also Published As

Publication number Publication date
JP2005517653A (ja) 2005-06-16
EP1453482A1 (en) 2004-09-08
CA2468986A1 (en) 2003-06-26
WO2003051335A1 (en) 2003-06-26
US20050063907A1 (en) 2005-03-24
EP1453482A4 (en) 2006-09-20
CN1589133A (zh) 2005-03-02
AUPR951501A0 (en) 2002-01-24
NZ532378A (en) 2005-02-25

Similar Documents

Publication Publication Date Title
BR0212052A (pt) Preparação de composição farmacêutica de liberação prolongada
BR0214159A (pt) Sistema farmacêutico radiopaco de liberação prolongada
BR0115965A (pt) Composições farmacêuticas para a liberação oral de agentes farmacologicamente ativos
CO5570662A2 (es) Formulacion farmaceutica que contiene 3-(3-dimetilamino-1- etil-2-metil-propil) fenol y proporciona una liberacion retardada del ingrediente activo
PL410219A1 (pl) Kompozycja zawierająca koniugat leku obejmujący pochodne kalicheamycyny i przeciwciało, oraz kompozycja farmaceutyczna ją zawierająca
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
BR0309528A (pt) Comprimido com alta carga de droga
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
CY1116520T1 (el) Φαρμακοτεχνικη μορφη fulvestrant
BR9910583A (pt) Aminotetralinas n-substituìdas como ligantes para o receptor de neuropeptìdeo y y5 úteis no tratamento de obesidade e outros distúrbios
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
ATE382337T1 (de) Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer
BRPI0203172B8 (pt) composição farmacêutica para acondroplasia
BR0210631A (pt) Composição farmacêutica de liberação prolongada
BR9916063A (pt) Composições auto-emulsificantes para medicamentos fracamente solúveis em água
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
BR0102040A (pt) Uso de paclitaxel estabilizado com albumina para preparação de uma droga para o tratamento de tumores sólidos e a droga desse modo obtida
BRPI0511966A (pt) composições farmacêuticas contendo polietileno glicol tendo um peso molecular menor do que 600 daltons
BR0007487A (pt) Difenil-uréias substituìdas com w-carbóxi-arilas como inibidores de raf cinase
BR9906920A (pt) "tts contendo um antioxidante"
ATE538797T1 (de) Pharmazeutische zusammensetzungen mit neuroaktivem steroid und verwendungen davon
DK1432402T3 (da) Sammensætning til tilförsel af lægemiddelkombinationer
BR0008509A (pt) Composição farmacêutica oral estabilizada contendo iodeto e iodato e método
BR0212931A (pt) Composição farmacêutica de liberação prolongada contendo metformina
ATE303137T1 (de) Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2112 DE 28/06/2011.